our science test page
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.
At Bristol Myers Squibb, we believe in the power of science to address some of the most challenging diseases of our time. Our focus on these unmet needs comes during a remarkable time, when unprecedented scientific breakthroughs are advancing the treatment of disease as never before in human history.
We work every day to transform patients’ lives through science. Each day, our employees around the world work together for patients – they are at the center of everything we do. They inspire us. They are the reason we come to work each day. We combine the agility of a biotech with the reach and resources of an established pharmaceutical company to create a global leading biopharma company powered by talented individuals who drive scientific innovation.
We are proud of the advancements we have made in oncology, hematology, immunology and cardiovascular disease, and we are dedicated to helping patients prevail over serious diseases through our diverse and promising pipeline and new scientific platforms.
As global citizens, we work sustainably and responsibly to create a positive impact in the communities where we live and work. We conduct our global business with the utmost integrity and transparency. We support programs, initiatives and organizations that help improve health, expand research opportunities, promote and expand STEM education and deliver basic human services to our communities.
We know that our responsibility goes beyond medicine. We promote health equity globally and strive to increase access to life-saving medicines for populations disproportionately affected by serious diseases and conditions. We achieve this in part through the Bristol Myers Squibb Foundation, which supports community-based programs that promote cancer awareness, screening, care and support among high-risk populations.
Our mission, vision, values and commitment
Bristol Myers Squibb is a global biopharma company firmly focused on its mission to discover, develop and deliver innovative medicines to patients with serious diseases.
Our focus on causal human biology and expertise in diverse platforms and therapeutic areas — including cell therapy, targeted protein degradation, radiopharmaceuticals, advanced small molecules, biotherapeutics, and antibody-drug conjugates — combined with a deep bench of modalities and innovative technologies, help us deliver best- and/or first-in-class programs.
Select targets with strong causal human biology
Match the right therapeutic modality to a molecular mechanism of action
Bridge from research to development with a clear path to clinical proof of concept
Accelerate
development
to get new, paradigm-
shifting medicines to patients faster
Ensure patients can access and benefit from transformational treatments
Our focus on causal human biology and expertise in diverse platforms and therapeutic areas — including cell therapy, targeted protein degradation, radiopharmaceuticals, advanced small molecules, biotherapeutics, and antibody-drug conjugates — combined with a deep bench of modalities and innovative technologies, help us deliver best- and/or first-in-class programs.
Our focus on causal human biology and expertise in diverse platforms and therapeutic areas — including cell therapy, targeted protein degradation, radiopharmaceuticals, advanced small molecules, biotherapeutics, and antibody-drug conjugates — combined with a deep bench of modalities and innovative technologies, help us deliver best- and/or first-in-class programs.
Our focus on causal human biology and expertise in diverse platforms and therapeutic areas — including cell therapy, targeted protein degradation, radiopharmaceuticals, advanced small molecules, biotherapeutics, and antibody-drug conjugates — combined with a deep bench of modalities and innovative technologies, help us deliver best- and/or first-in-class programs.
Our focus on causal human biology and expertise in diverse platforms and therapeutic areas — including cell therapy, targeted protein degradation, radiopharmaceuticals, advanced small molecules, biotherapeutics, and antibody-drug conjugates — combined with a deep bench of modalities and innovative technologies, help us deliver best- and/or first-in-class programs.
Our focus on causal human biology and expertise in diverse platforms and therapeutic areas — including cell therapy, targeted protein degradation, radiopharmaceuticals, advanced small molecules, biotherapeutics, and antibody-drug conjugates — combined with a deep bench of modalities and innovative technologies, help us deliver best- and/or first-in-class programs.